Filter
121
Text search:
non-inferiority
Featured
Recommendations
14
New Publications
20
Language
Document type
No document type
55
Guidelines
31
Studies & Reports
16
Manuals
8
Fact sheets
4
Situation Updates
3
Strategic & Response Plan
2
Training Material
1
Resource Platforms
1
Countries / Regions
Ethiopia
2
India
2
Zambia
2
South Africa
2
Global
2
Burkina Faso
1
Congo, Democratic Republic of
1
Ghana
1
Zimbabwe
1
South Sudan
1
Germany
1
Thailand
1
Rwanda
1
Papua New Guinea
1
Brazil
1
Ukraine
1
Angola
1
Latin America and the Carribbean
1
Western and Central Europe
1
Africa
1
Southern Africa
1
Russia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
33
Countries
15
Public Health
6
Women & Child Health
6
Pharmacy & Technologies
3
Capacity Building
1
Key Resources
1
Toolboxes
HIV
24
TB
18
COVID-19
16
NTDs
10
Rapid Response
4
Mental Health
4
AMR
4
NCDs
4
Caregiver
3
Cholera
2
Polio
2
Ebola
1
Refugee
1
Planetary Health
1
Pharmacy
1
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
WHO has issued a new recommendation on the length of bladder catheterization following surgical repair of a simple obstetric urinary fistula. Currently the length of catheterization is not standard and ranges from 5 to 42 days. The new guidance recommends a 7–10 day period of bladder catheterizati
...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te
...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and understanding of AMR). It is targeted specifically at health educators and policy planners, and applies
...
First Global Patient Safety Challenge Clean Care is Safer Care
The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to impro
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
The publication is designed to provide Ipas staff, trainers, partners and other health-care providers with access to up-to-date, evidence-based recommendations. In general, the recommendations are the same as those in the World Health Organization’s 2012 Safe Abortion: Technical and Policy Guidanc
...
PLOS Neglected Tropical Diseases September 2014 | Volume 8 | Issue 9 | e3016 DOI: 10.1371/journal.pntd.0003016
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
